Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
48.23
+0.25 (0.52%)
Jun 2, 2026, 1:11 PM EDT - Market open
Boston Scientific Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, Boston Scientific stock has a consensus rating of "Strong Buy" and an average price target of $79.37. The average 1-year stock price forecast is 64.57% higher than the current stock price, while the lowest is $55 (+14.04%) and the highest is $106 (+119.78%).
Price Target: $79.37 (+64.57%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 25 | 26 | 25 | 24 | 22 | 20 |
| Buy | 7 | 7 | 9 | 10 | 9 | 7 |
| Hold | 2 | 1 | 0 | 0 | 2 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 34 | 34 | 34 | 34 | 33 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $71 → $70 | Buy | Reiterates | $71 → $70 | +45.14% | Jun 1, 2026 |
| Wolfe Research | Wolfe Research | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | May 29, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 28, 2026 |
| Citi | Citi | Buy Maintains $87 → $70 | Buy | Maintains | $87 → $70 | +45.14% | May 28, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $100 | Buy | Maintains | $100 | +107.34% | May 28, 2026 |
Financial Forecast
Revenue This Year
21.62B
from 20.07B
Increased by 7.72%
Revenue Next Year
23.43B
from 21.62B
Increased by 8.35%
EPS This Year
2.73
from 1.94
Increased by 40.95%
EPS Next Year
2.87
from 2.73
Increased by 5.05%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 21.9B | ||
| Avg | 21.6B | ||
| Low | 21.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.1% | ||
| Avg | 7.7% | ||
| Low | 6.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.06 | ||
| Avg | 2.73 | ||
| Low | 2.19 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 57.7% | ||
| Avg | 41.0% | ||
| Low | 12.9% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.